NCT03944681View on ClinicalTrials.gov

Gender Influence on Torsadogenic Actions of Droperidol.

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 23, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Arrhythmia, Droperidol
Interventions
DRUG

Droperidol Injectable Solution

An electrocardiogram analysis in: 5,10,15,20 minutes after injection of 1.25 mg of droperidol used as PONV prophylaxis.

Trial Locations (1)

80211

Medical University of Gdansk, Gdansk

All Listed Sponsors
lead

Medical University of Gdansk

OTHER

NCT03944681 - Gender Influence on Torsadogenic Actions of Droperidol. | Biotech Hunter | Biotech Hunter